Kinetic GFR and Creatinine Trajectory

Clearance while the creatinine is still moving · v1

  • Use it when the creatinine is moving. Cockcroft-Gault, MDRD and CKD-EPI all assume a steady creatinine, so in acute kidney injury they report where the kidney was, not where it is.
  • Enter the steady-state baseline creatinine if one is known, then the creatinines measured during this illness with the hours between them.
  • You get the kinetic GFR for each interval and the clearance a static equation would have reported on the same blood.
  • You also get what that difference does to a renally cleared dose.
  • Read the direction, not only the value. The same number on a rising creatinine and on a falling one means two different things.

  • Children and adolescents under 18. The equation and the static comparators printed beside it are adult.
  • Staging of acute kidney injury. A stage needs urine output as well as creatinine, and staging on creatinine alone would understage the oliguric patient every time. The result points to the renal staging module.
  • The decision to start renal replacement therapy.
  • A dose for any named drug. The clearance is produced here and the dosing module applies it.

1. Patient Details

2. Creatinine Values

Optional. Supplying it anchors creatinine production to this patient rather than to a population estimate.
Creatinines Measured During This Illness 2 readings
Scope of this tool. It estimates clearance in an adult whose creatinine is moving. It is not valid once renal replacement therapy has started, and not valid across an interval that contains a dialysis session, because the fall in creatinine then reflects the machine rather than the kidney. It has not been validated in children. It assumes creatinine production is steady across the interval, which is not true in rhabdomyolysis, and it cannot see a drug that blocks tubular secretion of creatinine without changing the true GFR.

1. Why a Static Equation Cannot Be Used on a Moving Creatinine

Cockcroft-Gault, MDRD and CKD-EPI all solve the same balance: at steady state the creatinine cleared each day equals the creatinine the muscle makes each day, so a single value reports clearance. The moment clearance falls that equality breaks, creatinine accumulates in body water, and the measured value climbs towards a new plateau over two to three days. Read on the first morning of an injury, the static equation is reporting the clearance of the day before yesterday.

Waikar and Bonventre modelled it directly. Twenty-four hours after clearance fell by 90 per cent, creatinine had risen by about 1.8 to 2.0 mg/dL whatever the starting kidney function, but the proportional rise was 246 per cent with normal baseline function and only 47 per cent in stage 4 chronic kidney disease. The same injury looks entirely different depending on where the patient started, which is why the KDIGO creatinine criteria carry both an absolute and a relative arm.

2. What the Kinetic Equation Actually Does

Creatinine bookkeeping, not a new biomarker. Over the interval between two samples the muscle contributed a known quantity and the body retained a quantity readable from the rise in concentration multiplied by the volume it is dissolved in. The difference is what the kidney removed; divided by the average concentration, that is clearance.

TermWhat it isHow this tool obtains it
Creatinine production Milligrams of creatinine entering the blood each day, essentially a measure of muscle mass Anchored to the baseline creatinine when one is supplied, using the MDRD estimate at that value de-normalised by body surface area. Otherwise from age, sex and weight by Jelliffe's expression
Volume of distribution The water compartment the retained creatinine is dissolved in Total body water, taken as 0.6 times weight in men and 0.5 times weight in women. The reference implementation uses 0.6 for everybody, with no sex term, so this tool reads slightly differently from it in women
Maximum rise per day How fast creatinine would climb with no clearance at all Production divided by that volume. It is displayed in the result, because it sets the whole scale of the correction
Mean creatinine The average concentration the kidney was working against The arithmetic mean of the two values bounding the interval

3. The Number Every Other Calculator Hides

The maximum rise per day is the most influential constant in the equation, and published calculators handle it in two incompatible ways.

  • QxMD and Medscape fix it at 1.5 mg/dL per day for everybody, stating only that "the maximum rise in creatinine per day can be variable".
  • Chen's own group, in the 2019 dosing study, derived it per patient as production divided by volume of distribution, which is what this tool does and what the physiology requires: a 90 kg man with heavy muscle retains creatinine far faster than a 40 kg woman with none.

A derived figure for an average adult lands near 3 mg/dL per day, roughly double the fixed convention, and a larger figure makes the kinetic correction gentler, so the derived method reports the higher clearance of the two.

  • Both are printed, because they disagree and the lower number is the conservative one when dosing a drug with a narrow margin.
  • Observed rises in genuinely anuric patients are usually 1 to 2 mg/dL per day, below either figure, because production itself falls in critical illness through immobility, reduced intake and loss of muscle.

4. Reading the Direction, Not Only the Value

Creatinine isStatic equations thenConsequence at the drug chart
Rising Overestimate clearance, because the creatinine has not yet caught up with the injury Renally cleared drugs are given at too high a dose or too short an interval. This is the direction that accumulates cefepime, meropenem, vancomycin and colistin
Falling Underestimate clearance, because the creatinine still reflects yesterday's injury Recovering patients are left on renally reduced doses and are quietly under-treated. This is the commoner error in the second week of an intensive care stay
Steady Are valid, and the kinetic result converges on them No adjustment needed. Agreement between the two is itself the evidence that a steady state has been reached

5. When the Rise Is Faster Than Anuria Allows

If the observed rise exceeds production divided by volume of distribution the arithmetic returns a negative clearance, which is not a physiological state. The tool floors the estimate at zero and says so rather than printing a small confident number. Four explanations are worth working through.

  • The interval is wrong. The commonest cause. A sample timed from when it reached the laboratory rather than when it was drawn compresses a 24 hour gap into 8.
  • Creatinine production is not steady. Rhabdomyolysis releases creatinine and its precursors from muscle, so the rise reflects supply as much as failed clearance. Suspect it after crush injury, prolonged immobility, a seizure, snakebite or heavy exertion.
  • Secretion is blocked without a change in filtration. Trimethoprim, cimetidine, dolutegravir and cobicistat all raise creatinine by inhibiting its tubular secretion. Clearance of everything else is unchanged, so a dose reduction is not warranted.
  • Assay interference. The Jaffe method reads ketoacids, so creatinine may be falsely high in diabetic ketoacidosis. Enzymatic assays are not affected.

6. Where the Interval Is Too Short to Trust

Kinetic GFR divides a difference between two creatinines by the time between them, so run-to-run assay variation is amplified as the interval shortens.

  • Over 24 hours a 0.1 mg/dL discrepancy barely moves the answer; over 4 hours it can move it by tens of millilitres per minute.
  • This tool reports the span the estimate would cover if the pair were out by 0.1 mg/dL in either direction, and cautions below 6 hours.
  • A short interval is not useless, but it should not be the only thing a dose change rests on when a longer one is there for the taking.

7. Indian Context and Current Guidance

  • 107 critically ill patients, Bangalore tertiary centre, prospective. Using kinetic GFR rather than the CKD-EPI estimate changed the dose of at least one drug in 65 per cent of patients, most often vancomycin, acyclovir and meropenem.
  • 946 critically ill patients, ARDS Network fluid and catheter trial. Substituting the kinetic figure moved the Cockcroft-Gault dosing category in 33.5 per cent of those with acute kidney injury, and the effect was largest at the lowest clearances, where the dosing bands are narrowest.

Where therapeutic drug monitoring is rarely available on the day it is needed, the arithmetic is doing work that a vancomycin level would otherwise do.

The KDIGO 2012 acute kidney injury guideline remains the published standard.

  • The draft KDIGO 2026 guideline for acute kidney injury and acute kidney disease, released for public review in March 2026 and not yet published in final form, carries a suggestion to calculate kinetic estimated GFR in hospitalised adults with or at risk of acute kidney injury when an estimate of GFR under non-steady-state conditions will affect a clinical decision, graded 2B, and a practice point that kinetic GFR may be useful for dosing drugs excreted by the kidney.
  • That is a draft under revision, quoted here so you know where the guidance is heading. It should not be cited as current guidance until the final document appears.

8. What This Tool Deliberately Does Not Do

  • It does not stage acute kidney injury. Staging needs urine output as well as creatinine, and the KDIGO stage is set by whichever criterion is worse; a tool that staged on creatinine alone would understage the oliguric patient every time. Where the entered values meet the KDIGO creatinine criterion the result says so as one line of context, and points to the renal staging module.
  • It does not recommend renal replacement therapy.
  • It does not adjust any specific drug. The dosing module does that, from the clearance figure produced here.
Why this tool and MDCalc disagree on a falling creatinine. Both are built on Chen's kinetic GFR equation. When the creatinine is falling, the MDCalc keGFR calculator, checked in September 2026, leaves out the recovery term: it returns the baseline creatinine multiplied by the baseline MDRD eGFR, divided by the mean creatinine, and the hours between samples do not change the answer. This tool keeps that term, as the equation is published, and derives the maximum daily rise from the patient instead of fixing it at 1.5 mg/dL per day. Take an 82-year-old man of 65 kg, baseline 2.4 mg/dL, whose creatinine falls from 3.8 to 3.0 mg/dL over 24 hours. He reads about 25 mL/min here and 18 mL/min on MDCalc. That gap moves piperacillin-tazobactam, levofloxacin, cefuroxime and gentamicin into a different band. The MDCalc figure reads a recovering kidney low and can leave a beta-lactam under-dosed; for the aminoglycosides and colistin, levels decide. Over a short interval a fast fall can push the calculated figure above the patient's pre-illness clearance. Where a baseline creatinine is entered, this tool holds the working figure at that clearance and prints the calculated one beside it.
Abbreviations AKD (Acute Kidney Disease) · AKI (Acute Kidney Injury) · BMI (Body Mass Index) · BSA (Body Surface Area) · CKD (Chronic Kidney Disease) · CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) · CrCl (Creatinine Clearance) · eGFR (Estimated Glomerular Filtration Rate) · GFR (Glomerular Filtration Rate) · ICU (Intensive Care Unit) · IBW (Ideal Body Weight) · ISCCM (Indian Society of Critical Care Medicine) · KDIGO (Kidney Disease: Improving Global Outcomes) · KeGFR (Kinetic Estimated Glomerular Filtration Rate) · MDRD (Modification of Diet in Renal Disease) · RRT (Renal Replacement Therapy) · SBAR (Situation, Background, Assessment, Recommendation) · sCr (Serum Creatinine) · TBW (Total Body Water) · TDM (Therapeutic Drug Monitoring)
References
  1. Chen S. Retooling the creatinine clearance equation to estimate kinetic GFR when the plasma creatinine is changing acutely. J Am Soc Nephrol. 2013;24(6):877-888.
  2. Kwong YD, Chen S, Bouajram R, et al. The value of kinetic glomerular filtration rate estimation on medication dosing in acute kidney injury. PLoS One. 2019;14(11):e0225601.
  3. Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol. 2009;20(3):672-679.
  4. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1-138.
  5. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2026 clinical practice guideline for acute kidney injury and acute kidney disease. Public review draft, March 2026.
  6. Dinakar D, Chandan GS, Sreedhara R, et al. Kinetic estimated glomerular filtration rate and drug dosing in critically ill patients with acute kidney injury: a prospective observational study. Sci Prog. 2025;108(1):00368504251315806.
  7. Bairy M, Khoo B, Tan SH, et al. Using KeGFR for vancomycin dosing when renal clearance is acutely changing: a simulation study in a retrospective cohort. Kidney Med. 2025;7(4):100970.
  8. Mishra RC, Sodhi K, Prakash KC, et al. ISCCM guidelines on acute kidney injury and renal replacement therapy. Indian J Crit Care Med. 2022;26(suppl 2):S13-S42.
  9. Vairakkani R, Fernando ME, Sujith S, et al. Acute kidney injury in a tertiary care center of South India. Indian J Nephrol. 2022;32(3):206-215.
  10. Jelliffe RW, Jelliffe SM. A computer program for estimation of creatinine clearance from unstable serum creatinine levels, age, sex, and weight. Math Biosci. 1972;14(1-2):17-24.
  11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
  12. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247-254.
How to Cite This Tool

DOIhttps://doi.org/10.5281/zenodo.22401610

AMA Style:Umakanth S. Kinetic GFR and Creatinine Trajectory. Version 1. MEDiscuss Clinical Decision Support System. Published 2026. Accessed . https://mediscuss.org/cdss/kinetic-gfr. doi:10.5281/zenodo.22401610

Vancouver Style:Umakanth S. Kinetic GFR and Creatinine Trajectory [Internet]. Version 1. MEDiscuss.org; 2026 [cited ]. Available from: https://mediscuss.org/cdss/kinetic-gfr. doi:10.5281/zenodo.22401610

Disclaimer and scope
Disclaimer: This decision-support system is written for healthcare professionals. It does not substitute clinical judgment, and the treating physician retains absolute responsibility for every diagnostic, dosing and therapeutic decision. The algorithms are built on the evidence as it stands, and the evidence moves. Verify the output against your current institutional protocol, and against the patient in front of you.
© 2026 MEDiscuss.org. All rights reserved. Provided free of charge for clinical use. Unauthorised reproduction or redistribution is strictly prohibited.
Category Foundational CalculatorsCalculator
Specialties Nephrology, Critical Care, Internal Medicine

Written and maintained by

Dr Shashikiran Umakanth

Last revised 16 September 2026

How these tools are written and reviewed

Related Clinical Tools
Antimicrobial Dosing GuideAKI & CKD Staging PathwayICU Infusion & Inotropes